Prepare for your visit

David B Sabin

Optometrist · Tampa, FL · NPI 1952408429

One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.

What was reported

$1,007.41

in general payments reported to CMS, 2019-2025 · $578 in 2025

The $578 reported for 2025 was more than what 81% of Optometrist providers received nationally (typical 2025 total: $204).

Who reported paying

General payments only, top 6 by amount.

Bausch & Lomb Americas INC. $306.48
Abbvie INC. $141.67
Alcon Vision LLC $118.71
Amgen INC. $88.47
Johnson & Johnson Vision Care, INC. $88.26
Ani Pharmaceuticals, INC. $68.62

Drugs and devices associated with these payments

Infuse Lumigan Xen Glaucoma Treatment System Durysta Tepezza Total30 Purified Cortrophin Gel Oxervate Scoutpro Osmolarity System Omidria Acuvue Cequa

Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.

Questions you might ask

I saw David Sabin listed in the CMS Open Payments database. Can you tell me about your work with those companies?
Is there a generic or alternative to this medication, and would it work as well for me?
What made you choose this particular treatment for my situation?

These are normal questions. A good clinician will welcome them.

Notes

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.

GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/1045421/david-b-sabin